$LWLG (Internet/Data Center Related) Today, we are

New Post Public Reply Private Reply Replies (0) Message Board
mc67
216
$LWLG (Internet/Data Center Related) Today, we are currently working with leading integrated circuit (IC) vendors under NDA to validate our technology with their driver chips, with the goal of providing potential customers with prototypes that can be evaluated in their systems. Typically, a customer engagement process can be lengthy, but ultimately, very rewarding over the long-run. Having been actively engaged in the NDA process and prototype specification, testing and optimization, our next steps include more detailed discussions, performance feedback and further optimization towards an initial design-in. Due to confidentiality, we are unable to disclose details of our work with potential customers under NDA; although, we continue to introduce our technology to new potential customers such as silicon photonics foundries, component suppliers, high-speed module suppliers and networking equipment companies. Initial feedback has been very positive, and we plan to provide further announcements on this front as we are able.

https://lightwavelogic.com/

As we move forward, we expect our multi-pronged business model to provide Lightwave Logic with the flexibility to drive sustainable revenues over the long-term. Among these options are potentially an asset-light technology licensing model, the production and sale of components, or via a technology transfer with certain strategic customers.

https://lightwavelogic.com/Lightwave-Logic-Is...ate-Update

1) The first line bolded speaks to the "Limited Sampling" (field testing - "in their systems" ; investors need to understand that LWLG is DEEP into the Design-In Cycles of Tier 1's now, that being over 1 year, and LWLG is now onto the Final steps, Optimizing a couple of last parameters for the Limited Sampling before the Initial Design-In where LWLG product sales will begin for theit 1st Target Market of 10Km and greater

2) The second bolded line tells investors that deals can be done literally any time now, the technology is mature enough that companies like Intel, Facebook etc that want to get ahead of the game will see risk/reward as minimal based on LWLG proven results of developments and IP to-date, the real risk will become not being first to move to hitching their wagon to LWLG's technology, only a knucklehead would think progress doesn't matter, that is pure BS of those intent to negatively manipulate the PPS lower

Investors know that LWLG has been testing in MANY Tier 1's labs, yes THEIR LABS, for over a year now

Investors also know that LWLG is optimizing a couple of final parameters before beginning Limited Sampling in their systems, yes in THEIR SYSTEMS, this field testing is the final step in a Design In Cycle (a cycle which lasts on average 18 months) leading to Initial Design In where product sales begin, and ML has told investors LWLG is designed to scale to large volumes


Remember, LWLG's PkM Gen 2 device at 100Gbs NRZ OOK operating at 2.5V (soon to be sub 1V "Driverless"
$MJ
Scroll down for more posts ▼

Top 10 Most Recent News Articles

EmpowHer Grants Propel Female-led Social Ventures Forward

Updated Category News Views 8

Every now and then, you stumble upon a story that makes you take off your trading hat and put on your 'citizen of the world' one. The Boundless Futures Foundation is doing just that, pushing past the $1.5 million mark in grant funding to back female founders creating real scale impact. If this doesn't sound like a nonprofit turning the gears of change, I don't know what...

Continue Reading
Foodcare Proves Effective in Reducing Blood Sugar Levels

Updated Category News Views 6

A New Chapter for Diabetes Care: Foodcare Folks, we've got ourselves a game-changer in the world of diabetes care. Listen closely: Foodsmart's latest study, hot off the press from the American Heart Association's Circulation, essentially hands over the blueprint for tackling type 2 diabetes in an innovative fashion. Now, I'm not the type to get all mushy over scientific...

Continue Reading
Donatos Targets Texas: Pushing Franchise Growth Limits

Updated Category News Views 6

Donatos Pizza: Ambitious Expansion in the Lone Star State When you think about pizza chains expanding, Donatos Pizza might not be the first name to come to mind, but they're cooking up something big in Texas. Folks in Dallas and Houston better be ready because Donatos is rolling out the red carpet for its edge-to-edge, topping-loaded pies all over Texas. Strategic Growth:...

Continue Reading
Chad Tucker's Sequel Explores Deep Spiritual Themes

Updated Category News Views 6

An Honest Take: Faith, Growth, and Surrender A player in the world of spiritual growth literature has stepped up again, and it ain't holding back. Chad Tucker, a name perhaps familiar to folks following transformation tales soaked with faith, has released a beefy sequel to his first hit: The Lord in Us: If You Can Love an Enemy, You Can Love Anyone. Well, now he's back...

Continue Reading
American Savings Bank Surges 6% on NYSE Debut

Updated Category News Views 5

American Savings Bank Lands with a Bang on NYSE Who would have thought American Savings Bank's (NYSE: ASBH) entry onto the stock market would start with such gusto? It's not every day you see a debut that impressive, with shares soaring 6.25% right out of the gate. Guess it's safe to say the folks over at ASBH did something right in the lead-up to their NYSE launch. CEO...

Continue Reading
Airswift's Strategic Acquisition Boosts U.S. Energy Presence

Updated Category News Views 6

What's Driving Airswift's Latest Expansion? Airswift just dropped a bombshell by snapping up key businesses from New Tech Global (NTG), marking a serious power move in the U.S. energy sector. Now, what does this actually mean for investors? In blunt terms: they're muscling up their contractor base by a meaty 30%. That's no small feat. It's a calculated step to ace the...

Continue Reading
Trust vs. AI: Shapira's Fight in Modern Speechcraft

Updated Category News Views 5

Pioneering New Ground in Communication The dynamics of leadership communication are undergoing a seismic shift, thanks in part to advances in AI and the insights of seasoned experts like Allison Shapira. Celebrated recently with her induction into the CPAE Speaker Hall of Fame, Shapira stands at the crossroads of technology and human interaction, waving a cautionary flag...

Continue Reading
Beetles Gel Polish Unveils Vibrant Fall Nail Carnival

Updated Category News Views 6

Beetles Gel Polish Launches Fall Nail Carnival Here comes a new twist on fall fashion, and no, it ain’t your grandma's knitted sweater. We're talking nail polish—a vibrant, flashy ordeal brought to you by Beetles Gel Polish with their Fall Nail Carnival. They're rolling out this spectacle not just for your visions of grandeur nail ideas, but for those seeking deals...

Continue Reading
Andover Audio's FreePlay: Stereo Sound Goes Portable

Updated Category News Views 7

If there's one thing I've seen grow in leaps and bounds, it's the audio world. Andover Audio’s latest move? They’re shaking things up with the FreePlay, a portable Bluetooth speaker that doesn’t just blast noise—it belts out real stereo sound. Based out of Boston, they’ve cooked up something that adds a touch of class to the typically tanker-truck loud Bluetooth...

Continue Reading
Metriport Eyes Major Step in Health Data Integration

Updated Category News Views 6

Metriport's Push into the TEFCA Framework Son of a gun, Metriport's making noise in the health data world! They just got the nod as a Candidate QHIN under the Trusted Exchange Framework and Common Agreement, or TEFCA if you're into acronyms. This isn't just some digital high-five; it's a significant stride forward for healthcare data exchange. Now they're smack in the...

Continue Reading

Top 5 Most Recently Viewed Articles

Alcresta Therapeutics Initiates Patient Enrollment for RELiZORB Trial

Updated Category News Views 134

Alcresta Therapeutics Engages in Groundbreaking Clinical Trials Alcresta Therapeutics, Inc. is at the forefront of innovation in medical care, particularly in the realm of enzyme-based products. Recently, the company made an exciting announcement regarding its investigator-initiated trial at Inova Fairfax Medical Campus, which has just enrolled its first patient. This...

Continue Reading
Kaskela Law LLC Investigates Blue Ridge Bankshares Shareholders

Updated Category News Views 47

Kaskela Law LLC Investigates Blue Ridge Bankshares Shareholders Kaskela Law LLC is making headlines as it launches an investigation into Blue Ridge Bankshares, Inc. (NYSE: BRBS). This investigation is particularly focused on long-term shareholders of Blue Ridge, who may have suffered due to recent issues related to the company's financial reporting and practices....

Continue Reading
Exploring Net Asset Value for Octopus AIM VCT 2 plc Shares

Updated Category News Views 158

Understanding Net Asset Value When it comes to investments, especially in publicly traded companies, understanding net asset value (NAV) is critical. For Octopus AIM VCT 2 plc, the recent reports indicate that the NAV stands at approximately 37.3 pence per Ordinary share. This figure is essential for current and potential investors as it provides insight into the...

Continue Reading
Banzai Welcomes Michael Kurtzman as New Chief Revenue Officer

Updated Category News Views 230

Banzai Appoints Michael Kurtzman as Chief Revenue Officer Veteran Revenue and Go-to-Market Executive to Scale Leading Video Engagement, Production, and Webinar Solutions Introduction of Michael Kurtzman SEATTLE — Banzai International, Inc. (NASDAQ: BNZI), a prominent marketing technology company, is thrilled to announce Michael Kurtzman has joined the team as the new...

Continue Reading
FibroBiologics Secures $1.5 Million in Direct Stock Offering

Updated Category News Views 122

FibroBiologics Closes Successful Funding Round FibroBiologics, Inc. (NASDAQ: FBLG), a prominent clinical-stage biotechnology firm, has successfully finalized a registered direct offering valued at $1.5 million. This notable transaction underscores the company's commitment to advancing its research and development initiatives centered around chronic disease therapeutics....

Continue Reading